News articles about Intermolecular (NASDAQ:IMI) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Intermolecular earned a media sentiment score of 0.21 on Accern’s scale. Accern also gave news coverage about the semiconductor company an impact score of 45.6290001502701 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the news articles that may have impacted Accern Sentiment’s scoring:

Separately, ValuEngine upgraded Intermolecular from a “strong sell” rating to a “sell” rating in a research note on Monday, August 7th.

Intermolecular (NASDAQ:IMI) traded down $0.04 during trading on Tuesday, reaching $1.12. The company’s stock had a trading volume of 11,737 shares, compared to its average volume of 34,827. Intermolecular has a twelve month low of $0.78 and a twelve month high of $1.20.

In related news, major shareholder Lloyd I. Miller III acquired 34,109 shares of Intermolecular stock in a transaction dated Friday, September 1st. The shares were acquired at an average cost of $0.86 per share, for a total transaction of $29,333.74. Following the completion of the purchase, the insider now owns 70,368 shares in the company, valued at $60,516.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last quarter, insiders bought 38,930 shares of company stock worth $33,480. Insiders own 45.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Intermolecular (IMI) Share Price” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/07/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-intermolecular-imi-share-price.html.

About Intermolecular

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Stock Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related stocks with our FREE daily email newsletter.